Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

ROSWELL PARK CANCER INSTITUTE

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Glutamine in Treating Side Effects in Children Who Are Undergoing Stem Cell Transplantation

Phase 2

Completed

Conditions: Oral Complications
Unspecified Childhood Solid Tumor, Protocol Specific

First Posted Date: 2004-06-17

Last Posted Date: 2011-03-01

Lead Sponsor: Roswell Park Cancer Institute

Target Recruit Count: 120

Registration Number: NCT00003898

Locations: 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
🇺🇸
Simmons Cancer Center - Dallas, Dallas, Texas, United States

Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid Tumors

Phase 1

Completed

Conditions: Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2004-06-11

Last Posted Date: 2014-01-13

Lead Sponsor: Roswell Park Cancer Institute

Target Recruit Count: 53

Registration Number: NCT00084708

Locations: 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States

Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal Cancer

Phase 1

Completed

Conditions: Colorectal Cancer
Diarrhea

First Posted Date: 2004-06-11

Last Posted Date: 2013-01-31

Lead Sponsor: Roswell Park Cancer Institute

Target Recruit Count: 2

Registration Number: NCT00084721

Locations: 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States

Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladder

Phase 2

Completed

Conditions: Extrahepatic Bile Duct Cancer
Gallbladder Cancer

First Posted Date: 2004-06-11

Last Posted Date: 2012-01-12

Lead Sponsor: Roswell Park Cancer Institute

Registration Number: NCT00084942

Locations: 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States

Docetaxel, Capecitabine, and Cisplatin in Treating Patients With Advanced Solid Tumors

Phase 1

Completed

Conditions: Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2004-06-11

Last Posted Date: 2023-08-04

Lead Sponsor: Roswell Park Cancer Institute

Target Recruit Count: 61

Registration Number: NCT00084734

Locations: 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States

Calcitriol and Dexamethasone Before Radical Prostatectomy in Treating Patients With Localized Adenocarcinoma (Cancer) of the Prostate

Phase 2

Terminated

Conditions: Prostate Cancer

Interventions: Other: clinical observation
Dietary Supplement: calcitriol
Drug: dexamethasone

First Posted Date: 2004-06-11

Last Posted Date: 2017-06-12

Lead Sponsor: Roswell Park Cancer Institute

Target Recruit Count: 25

Registration Number: NCT00084864

Locations: 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States

BCG Plus Interferon Alfa 2b in Treating Patients With Bladder Cancer

Phase 2

Completed

Conditions: Bladder Cancer

First Posted Date: 2004-05-21

Last Posted Date: 2013-02-01

Lead Sponsor: Roswell Park Cancer Institute

Registration Number: NCT00004122

Locations: 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States

Gallium Nitrate in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma

Phase 2

Completed

Conditions: Lymphoma

First Posted Date: 2004-05-20

Last Posted Date: 2015-10-06

Lead Sponsor: Roswell Park Cancer Institute

Target Recruit Count: 35

Registration Number: NCT00002578

Locations: 🇺🇸
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸
Albert Einstein Comprehensive Cancer Center, Bronx, New York, United States
🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States

Doxorubicin in Treating Patients With AIDS-Related Kaposi's Sarcoma

Phase 3

Completed

Conditions: Sarcoma

First Posted Date: 2004-05-19

Last Posted Date: 2013-02-04

Lead Sponsor: Roswell Park Cancer Institute

Registration Number: NCT00002985

Locations: 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States

Diagnostic Procedure for Identifying Patients With Metastatic Colorectal Cancer

Not Applicable

Completed

Conditions: Colorectal Cancer
Metastatic Cancer

First Posted Date: 2004-05-19

Last Posted Date: 2013-02-05

Lead Sponsor: Roswell Park Cancer Institute

Registration Number: NCT00003186

Locations: 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy